Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

about

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF.

P2860

Q36297613-B2CEB025-C8FC-4F9F-8750-8F8426BEF7A4 Q50943114-D20CC434-0248-49F7-A508-0DE8A79A45E6

P2860

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

Item

http://www.wikidata.org/entity/Q35933773

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@ast

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@en

type

Item

label

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@ast

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@en

prefLabel

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@ast

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@en

P1476

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

@en

P2093

Liyuan Ma

http://www.w3.org/2001/XMLSchema#string

Neepa Shah

http://www.w3.org/2001/XMLSchema#string

Purak C Parikh

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

Identification of patients with diabetic macular edema from claims data: a validation study.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.

Treatment patterns for neovascular age-related macular degeneration: analysis of 284 380 medicare beneficiaries.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.

P304

e0149450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0149450

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian L VanderBeek

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26909797

http://www.w3.org/2001/XMLSchema#string

P932

4765886

http://www.w3.org/2001/XMLSchema#string

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

about

P2860

P2860

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932